Once mixed keep refrigerated
A.FreundT
doi: 10.1172/jci.insight.133429 Summary Keywords GLP-1 receptor agonists, type 2 diabetes, eating behavior, weight loss, personalized medicine Citation Koide Y, Kato T, Hayashi M, Daido H, Maruyama T, Ishihara T, Nishimura K, Tsunekawa S and Yabe D (2025) Association between eating behavior patterns and the therapeutic efficacy of GLP-1 receptor agonists in individuals with type 2 diabetes: a multicenter prospective observational study
But the addition of glucagon receptor activation in retatrutide appears to provide an incremental but meaningful advantage, particularly for liver fat reduction and energy expenditure
Medicina, 61(2), 291
Lilly Direct Zepbound vials : $299 12 (2.5 mg) = $3,588/year, or $449 12 (7.515 mg) = $5,388/year